Interact to see
Advertisement
Advertisement
CLBFX vs FFAMX
CLBFX vs FFAMX Comparison
Open Charts CLBFX vs FFAMX
CLBFX vs FFAMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CLBFX vs. FFAMX commentary
Jul 12, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Buy and FFAMX is a Buy.
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 288B vs. FFAMX (10.9B). CLBFX (1.92) and FFAMX (1.90) have matching dividends . CLBFX was incepted earlier than FFAMX: CLBFX (24 years) vs FFAMX (20 years). FFAMX (0.85) is less costly to investors than CLBFX (0.66). CLBFX is a more actively managed with annual turnover of: 50.00 vs. FFAMX (25.00). FFAMX has a lower initial minimum investment than CLBFX: FFAMX (0) vs CLBFX (250). CLBFX annual gain was more profitable for investors over the last year : 12.16 vs. FFAMX (10.51). CLBFX return over 5 years is better than : 36.21 vs. FFAMX (16.79).
| CLBFX | FFAMX | CLBFX / FFAMX | |
| Total Expense Ratio | 0.66 | 0.82 | 80% |
| Annual Report Gross Expense Ratio | 0.66 | 0.85 | 78% |
| Fund Existence | 24 years | 20 years | - |
| Gain YTD | 8.964 | 8.672 | 103% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 288B | 10.9B | 2,642% |
| Annual Yield % from dividends | 1.92 | 1.90 | 101% |
| Returns for 1 year | 12.16 | 10.51 | 116% |
| Returns for 3 years | 42.54 | 33.23 | 128% |
| Returns for 5 years | 36.21 | 16.79 | 216% |
| Returns for 10 years | 97.00 | 61.25 | 158% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HFAFX | 18.07 | 0.14 | +0.78% |
| Hartford Schroders Intl Cntrrn Val R5 | |||
| GLBIX | 10.76 | 0.04 | +0.37% |
| Leuthold Global Institutional | |||
| BRWVX | 30.04 | 0.11 | +0.37% |
| MFS Blended Research Growth Eq R6 | |||
| MIDHX | 34.07 | 0.12 | +0.35% |
| MFS International New Discovery R3 | |||
| LGOAX | 54.25 | 0.06 | +0.11% |
| Patient Opportunity A | |||